Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

GeneDx Holdings (WGS) Leases (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Leases for 6 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases fell 8.45% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 8.45% decrease, with the full-year FY2025 number at $2.9 million, down 8.45% from a year prior.
  • Leases was $2.9 million for Q4 2025 at GeneDx Holdings, down from $24.2 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $44.0 million in Q2 2022 to a low of $2.9 million in Q4 2025.
  • A 5-year average of $24.2 million and a median of $25.0 million in 2025 define the central range for Leases.
  • Peak YoY movement for Leases: skyrocketed 105.92% in 2022, then crashed 60.02% in 2023.
  • GeneDx Holdings' Leases stood at $21.4 million in 2021, then crashed by 59.76% to $8.6 million in 2022, then crashed by 60.02% to $3.4 million in 2023, then decreased by 7.76% to $3.2 million in 2024, then decreased by 8.45% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Leases are $2.9 million (Q4 2025), $24.2 million (Q3 2025), and $25.0 million (Q2 2025).